Real-time enrollment status for this macular degeneration clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT06856577 |
| Recruiting Status | Recruiting |
| Condition | Macular Degeneration |
| Phase | Clinical Trial |
| Target Enrollment | 284 participants |
| Active Locations | 74 sites in the US |
| Sponsor | Adverum Biotechnologies, Inc. |
| Last Updated on CT.gov | November 18, 2025 (Nov 18, 2025) |
As of March 2, 2026: Clinical trial NCT06856577 is currently recruiting participants. This clinical trial study for macular degeneration is actively seeking new participants at 74 locations across the United States. The study is sponsored by Adverum Biotechnologies, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06856577 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 74 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06856577 was last updated Nov 18, 2025 (November 18, 2025). HelloStudys verifies this status automatically.